Vaccinations

UK invests billions in new biosecurity centre to strengthen pandemic preparedness

UK invests billions in a National Biosecurity Centre in Essex: Europe’s largest hub for vaccine development, and pandemic preparedness.

Scientists say vaccines less effective against Delta variant

According to a new study, the antibodies created by the Pfizer vaccine are on average less effective against the Delta variant.

MHRA approves Pfizer vaccine for 12-15-year-olds

The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.

WHO gives emergency approval to Sinovac COVID-19 vaccine

The World Health Organisation (WHO) has given emergency approval to the Sinovac COVID-19 vaccine - because there is ongoing "access inequity" for countries in the Global South.

COVID-19 vaccines & genetic modification

Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.

UK approves use of single-dose Johnson & Johnson COVID vaccine

The UK today (28 May) approves use of the single-dose Johnson & Johnson vaccine that provides enough protection against the virus in one injection.

Scientists link AstraZeneca vaccine to arterial blood clots

Over the last three months, scientists have been tracing rare instances of blood clots in veins in connection to the AstraZeneca COVID vaccine - now, they have the first evidence of arterial blood clots, which can cause stroke.

What are the side effects of the Johnson & Johnson vaccine?

Here, we discuss some of the common misconceptions about side effects of the Johnson & Johnson COVID vaccine.

Digital tech in response to the COVID-19 pandemic

Justin Nogarede, FEPS Digital Policy Analyst, says that while digital tech can’t solve everything, can it solve anything? Read on to find out about the role of digital tech in the COVID-19 pandemic.

Moderna say COVID vaccine 100% effective in 12-17 year olds

The Moderna vaccine has been found to be 100% effective against COVID-19 in 12-17 year olds, according to new data from the TeenCOVE study.

PHE say one dose of vaccine 33.5% effective against Indian variant

Public Health England have found that both Pfizer and AstraZeneca vaccines against the Indian variant would have an efficacy of 33.5% in one dose.

COVID patients have antibodies “11 months after first symptoms”

Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".

Parliament and Council agree on EU Digital COVID Certificate proposal

The European Parliament and the Council have reached an agreement on the Commission's proposal of the EU Digital COVID Certificate.

Commission signs third contract for 1.8 billion BioNTech-Pfizer doses

The European Commission has announced that it has signed a third contract to secure an additional 1.8 billion BioNTech-Pfizer vaccine doses.

Logistics & supply chain will win the COVID-19 war

Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.

EU4Health: Building healthcare systems of tomorrow

European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.

COVID-19 and its impact on society

European Public Health Association Executive Director, Dineke Zeegers Paget, updates us about COVID-19 and its impact on society, public health, healthcare and equitable access to vaccines.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders